Literature DB >> 9821274

Adeno-associated virus expression systems for gene transfer.

J E Rabinowitz1, J Samulski.   

Abstract

In contrast to other gene delivery systems, adeno-associated virus vectors show long term gene expression without immune response or toxicity. New production methods have increased vector titers and eliminated adenovirus contamination, thereby facilitating effective in vivo use. These advancements will expedite additional animal model studies providing validation for use of this vector in human clinical trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9821274     DOI: 10.1016/s0958-1669(98)80031-1

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  30 in total

1.  Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.

Authors:  Padmaja B Thomas; Deedar M Samant; Shivaram Selvam; Rui Hua Wei; Yanru Wang; Douglas Stevenson; Joel E Schechter; Florence Apparailly; Austin K Mircheff; Melvin D Trousdale
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Cell targeting in anti-cancer gene therapy.

Authors:  Mohd Azmi Mohd Lila; John Shia Kwong Siew; Hayati Zakaria; Suria Mohd Saad; Lim Shen Ni; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2004-01

4.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice.

Authors:  K Goudy; S Song; C Wasserfall; Y C Zhang; M Kapturczak; A Muir; M Powers; M Scott-Jorgensen; M Campbell-Thompson; J M Crawford; T M Ellis; T R Flotte; M A Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

5.  Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.

Authors:  Dawn E Bowles; Joseph E Rabinowitz; R Jude Samulski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Noninvasive measurement of gene expression in skeletal muscle.

Authors:  G Walter; E R Barton; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 7.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

8.  Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Authors:  P Wu; W Xiao; T Conlon; J Hughes; M Agbandje-McKenna; T Ferkol; T Flotte; N Muzyczka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 9.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

10.  Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.

Authors:  J Adriaansen; M Khoury; C J de Cortie; F J Fallaux; P Bigey; D Scherman; D J Gould; Y Chernajovsky; F Apparailly; C Jorgensen; M J B M Vervoordeldonk; P P Tak
Journal:  Ann Rheum Dis       Date:  2007-03-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.